Navigation Links
ARIUS Announces Third Quarter Fiscal 2007 Financial Results
Date:10/12/2007

he increases were primarily the result of increased product development activity, including process development and scale-up, as the Company prepares several of its programs for the clinic as well as an increase in staffing levels and stock option remuneration expense.

General and administrative expenses increased to $2,833,070 for the nine-month period ended August 31, 2007, compared to $2,162,020 for the same period in fiscal 2006. For the three-month period ended August 31, 2007, the Company's general and administrative expenses increased to $1,160,827 compared to $470,619 for the same period in fiscal 2006. The increases were primarily the result of increased head count, stock option remuneration, and severance costs, partially offset by decreased consulting and legal costs.

As at August 31, 2007, the Company's cash and cash equivalents, short-term investments and working capital position were $6,201,996, $7,962,663 and $12,035,539 respectively, compared with November 30, 2006 balances of $4,077,065, $16,135,490 and $20,263,807, respectively. The Company believes that it has adequate financial resources for anticipated expenditures until the fourth quarter of fiscal 2008.

As at October 10, 2007, the Company had: 44,750,964 Common Shares outstanding; 34,953,526 Warrants; 2,121,808 Compensation Warrants; and 4,019,705 Stock Options.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 400 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Kauten. Source: Teresa Esser. Ralph is one of the ... bioscience, said Frank Langley, president and CEO of Point One ... to admit that his success in high-tech entrepreneurship is somehow ... said in an interview. Ive been a lucky guy. , ...
... Wisconsin could lose its carefully established position as ... more money is not channeled into academic and other research ... the report (5.4 MB PDF) This prediction comes ... the governor on technological matters. The report, titled The Economic ...
... The difficult part is finding meaning. When researching the ... of information. , ,The differences between information and intelligence ... process for gathering information ensures that the results will ... well-defined purpose allows you to search the Internet broadly ...
Cached Biology Technology:Ralph Kauten on how to raise angel financing 2Ralph Kauten on how to raise angel financing 3Ralph Kauten on how to raise angel financing 4Economic report raises red flags on Wisconsin's future 2Economic report raises red flags on Wisconsin's future 3Are you gathering information or intelligence about competitors? 2Are you gathering information or intelligence about competitors? 3
(Date:7/9/2014)... PA, July 10, 2014 Inflammatory diseases can ... patient, complicating treatment because a medication effective for ... example is the anti-arthritic medication dexamethasone, which alleviates ... A study in the August issue of ... effects of a new class of anti-arthritic drugs, ...
(Date:7/9/2014)... found in the bladders of healthy women differ ... of incontinence, according to researchers from Loyola University ... findings, published July 9, 2014, in the American ... suggest that bacterial communities may play a role ... (UUI) is a common, yet poorly understood, condition ...
(Date:7/9/2014)... ranges in which animals can be found, concern mounts ... an increased range for a host mean new territory ... a team of UC Santa Barbara scientists, including parasitologists ... in the Journal of Biogeography , Hechinger, Kuris ... may happen: Hosts may actually lose their parasites when ...
Breaking Biology News(10 mins):New class of anti-arthritis drugs effectively treats multiple inflammatory diseases 2Not at home on the range 2Not at home on the range 3Not at home on the range 4
... This release is available in French . ... on an extremely important process for the proper functioning ... transportation pathway of ,cargo, to and from the surface ... have severe consequences, leading to numerous diseases such as ...
... French . , Qubec City, March ... surfaces are believed to be ineffective in eliminating noroviruses, ... of all foodborne gastroenteritis outbreaks. According to a recent ... Journal of Food Protection , only bleach-based disinfectants drastically ...
... New Orleans, LA Research led by Wayne L. Backes, ... LSU Health Sciences Center New Orleans School of Medicine, has ... are present in an individual, but also how they interact, ... is safely eliminated from the body or is converted into ...
Cached Biology News:Getting turned on 2Getting turned on 340 percent of surface disinfectants ineffective in eliminating viruses that cause gastroenteritis 2LSUHSC research increases understanding of drug metabolism 2
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: